GSK-3 Inhibitors: A New Class of Drugs for Alzheimer's Disease Treatment.

Pal, Dilipkumar; Mukherjee, Souvik; Song, In-Ho; Nimse, Satish B

Pal, Dilipkumar; Mukherjee, Souvik; Song, In-Ho; Nimse, Satish B.

Afiliación

Pal D; Department of Pharmaceutical Sciences, Guru Ghasidas Viswavidyalaya (A Central University), Bilaspur, Chhattisgarh, 495009, India.
Mukherjee S; Department of Pharmaceutical Sciences, Guru Ghasidas Viswavidyalaya (A Central University), Bilaspur, Chhattisgarh, 495009, India.
Song IH; Institute of Applied Chemistry and Department of Chemistry, Hallym University, Chuncheon 200702, Korea.
Nimse SB; Institute of Applied Chemistry and Department of Chemistry, Hallym University, Chuncheon 200702, Korea.

Curr Drug Targets ; 22(15): 1725-1737, 2021.

Article en En | MEDLINE | ID: mdl-33459229

Asunto(s)

Enfermedad de Alzheimer; Glucógeno Sintasa Quinasa 3/antagonistas & inhibidores; Enfermedad de Alzheimer/tratamiento farmacológico; Humanos; Fosforilación; Proteínas tau/metabolismo

Palabras clave

Alzheimer's disease; GSK-3; GSK-3 inhibitors; Tau; neurodegenerative diseases; protein kinase.; ß-amyloid

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Glucógeno Sintasa Quinasa 3 / Enfermedad de Alzheimer Límite: Humans Idioma: En Revista: Curr Drug Targets Asunto de la revista: TERAPIA POR MEDICAMENTOS Año: 2021 Tipo del documento: Article País de afiliación: India Pais de publicación: Emiratos Árabes Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google